Top Story

VIDEO: Wide choice of therapeutic options available for menopause symptoms

March 6, 2015

SAN DIEGO — In this video exclusive, JoAnne E. Manson, MD, DrPh, FACP, FACE, of Brigham and Women’s Hospital and Harvard Medical School in Boston, discusses personalized menopause management, including clinical and biomarker data that help inform decision making.

According to Manson, treatment options for menopause have expanded greatly over the years and include hormonal and non-hormonal options. Some women are not good candidates for hormone therapy, and it is important for clinicians to understand the personal preference of their patients, she added.

Giuseppe Grande Meeting News Coverage

Soluble urokinase receptor presents biomarker for urogenital tract inflammation

March 6, 2015
SAN DIEGO — Soluble urokinase-type plasminogen activator receptor, or suPAR, a known marker of systemic inflammation, is detectable in semen, according to research…
Meeting News Coverage

Abaloparatide lowers fracture risk in postmenopausal osteoporosis

March 6, 2015
SAN DIEGO — A synthetic form of human parathyroid hormone-related protein, abaloparatide, significantly reduced the rate of new fractures in women with…
Ralph A. DeFronzo Meeting News Coverage

Liraglutide improves weight, HbA1c in overweight/obese adults with type 2 diabetes

March 5, 2015
SAN DIEGO — More patients with overweight and obesity achieved clinically meaningful weight loss with liraglutide 3 mg and 1.8 mg compared with placebo, according…
Peter Clayton Meeting News Coverage

Summer daylight exposure linked to growth in GH-deficient children

March 5, 2015
SAN DIEGO — Genes modulating growth and summer daylight exposure are subject to a complex gene–environment interaction in response to recombinant human…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
thumbnail for video 4006825234001

The impact of obesity on orthopedic care

January 23, 2015
KOLOA, Hawaii – At Orthopedics Today Hawaii 2015, Thomas P. Schmalzried, MD, discusses the impact the obesity…
More »
CME
Assessing Cornerstones for Successful Weight Loss

Assessing Cornerstones for Successful Weight Loss: Building a Foundation that Really Works

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc.

Obesity has increased dramatically in the past 2 decades and is now considered a health care epidemic in the United…
More »
Current Issues
View the Current Issues
morganatic-roan